Nasal Spray

1. If persistent nasopharyngeal irritation occurs, it may be an indication for stopping BECONASE AQ Nasal Spray.
2. The replacement of a systemic corticosteroid with BECONASE AQ Nasal Spray can be accompanied by signs of adrenal insufficiency. (Web site)
3. BECONASE AQ Nasal Spray is indicated for the relief of the symptoms of seasonal or perennial allergic and nonallergic (vasomotor) rhinitis.

Beconase Aq

1. Use of excessive doses of BECONASE AQ Nasal Spray may suppress HPA function.
2. Instead, nasal vasoconstrictors or oral antihistamines may be needed until the effects of BECONASE AQ Nasal Spray are fully manifested.
3. Adverse reactions reported in controlled clinical trials and open studies in patients treated with BECONASE AQ Nasal Spray are described below.

Aq Nasal

1. Patients should use BECONASE AQ Nasal Spray at regular intervals since its effectiveness depends on its regular use.
2. Because other corticosteroids are excreted in human milk, caution should be exercised when BECONASE AQ Nasal Spray is administered to a nursing woman.
3. If such changes occur, BECONASE AQ Nasal Spray should be discontinued slowly consistent with accepted procedures for discontinuing oral steroid therapy.
4. This page contains recent news articles, when available, and an overview of Beconase AQ but does not offer medical advice. (Web site)

Spray Should

1. BECONASE AQ Nasal Spray should not be continued beyond 3 weeks in the absence of significant symptomatic improvement. (Web site)
2. BECONASE AQ Nasal Spray should not be used in the presence of untreated localized infection involving the nasal mucosa.
3. Patients being treated with Beconase Aq Nasal Spray should receive the following information and instructions. (Web site)

Inhalation Aerosol

1. The safety and effectiveness of BECONASE AQ Nasal Spray in children below 6 years of age have not been established.
2. PEDIATRIC USE: Safety and effectiveness of BECONASE Inhalation Aerosol in children below 6 years of age have not been established.
3. Therefore, larger than recommended doses of BECONASE Inhalation Aerosol and BECONASE AQ Nasal Spray should be avoided.

Nasal Polyps

1. BECONASE AQ Nasal Spray is also indicated for the prevention of recurrence of nasal polyps following surgical removal. (Web site)
2. For BECONASE AQ Nasal Spray to be effective in the treatment of nasal polyps, the spray must be able to enter the nose.
3. The full benefit of BECONASE AQ Nasal Spray may take a few days to develop.
4. Prescription nasal corticosteroid sprays include beclomethasone (Beconase AQ), fluticasone (Flonase) and budesonide (Rhinocort).

Relief

1. Fewer than 5 per 100 patients reported headache, nausea, or lightheadedness following the use of BECONASE AQ Nasal Spray.
2. Each bottle of BECONASE AQ Nasal Spray will provide at least 200 metered doses.
3. Caution: BECONASE AQ Nasal Spray is not intended to give rapid relief of your nasal symptoms.
4. In such cases it is advisable to use a nasal vasoconstrictor during the first 2 to 3 days of therapy with BECONASE AQ Nasal Spray.
5. Cases of growth suppression have been reported for intranasal corticosteroids, including BECONASE AQ (see PRECAUTIONS: Pediatric Use).
6. Books about "Beconase" in Amazon.com
   

Continue: More Keywords - - - - - - - - - -